Global Use of Idarucizumab in Clinical Practice: Outcomes of the RE-VECTO Surveillance Program

Thrombosis and Haemostasis - Germany
doi 10.1055/s-0039-1695771
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Georg Thieme Verlag KG

Related search

Monitoring Ambulatory Care: Impact of a Surveillance Program on Clinical Practice Patterns in New York City.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1980English

Use of Pharmacogenetic Testing in Routine Clinical Practice Improves Outcomes for Psychiatry Patients

Journal of Psychiatry
2016English

Improved Clinical Outcomes in Patients With Positive Blood Culture by Proactive Intervention of Antimicrobial Use—Impact of Antimicrobial Stewardship Program Implementation on Clinical Practice

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2017English

The Use of Nursing Diagnoses in Clinical Practice

Central European Journal of Nursing and Midwifery
Nursing
2014English

The Use of NT-proBNP in Clinical Practice

South African Family Practice
2004English

Adverse Clinical Outcomes After Dabigatran Reversal With Idarucizumab to Facilitate Acute Stroke Thrombolysis

Journal of Neurology
Neurology
2017English

Using Outcomes Research in Clinical Practice

BMJ
1994English

Safe Use of Meloxicam in Clinical Practice

Medical Council
2019English

Azithromycin Use in Clinical Practice

ACTUAL INFECTOLOGY
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy